Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2013
10/24/2013US20130281492 Novel oxazolidinone derivatives
10/24/2013US20130281450 Isoindolone derivatives
10/24/2013US20130281443 Inhibitors of focal adhesion kinase
10/24/2013US20130281434 Therapeutic compounds
10/24/2013US20130281433 Therapeutic compounds
10/24/2013US20130281406 Thiazole derivatives and their use as p2y12 receptor antagonists
10/24/2013US20130280169 Central nervous system tissue-labeling composition, method for labeling central nervous system tissue, and screening method using central nervous system tissue-labeling composition
10/24/2013CA2850881A1 Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
10/23/2013EP2653468A1 Bicyclic Compound and Use Thereof for Medical Purposes
10/23/2013EP2651931A1 Fused dihydropyrans as gpr119 modulators for the treatment of diabetes, obesity and related diseases
10/23/2013EP2651930A1 Biarylamide inhibitors of leukotriene production
10/23/2013EP2651928A2 Anti-viral compounds
10/23/2013EP2651901A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
10/23/2013EP2651893A1 Sulfur derivatives as chemokine receptor modulators
10/23/2013EP2651890A1 Strigolactam derivatives and their use as plant growth regulators
10/23/2013CN103360385A Compound and medicament for treating MRSA (Methicillin-resistant Staphylococcus Aureus) infection
10/23/2013CN103360384A Synthetic method for key intermediate of HMG-CoA reductase inhibitor
10/23/2013CN103360383A Crystal form B of lurasidone hydrochloride and preparation method thereof
10/23/2013CN103360317A Dicyclo-substituted pyrazolone azo derivatives, as well as preparation method and use thereof
10/23/2013CN101657443B [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
10/22/2013US8563746 Cyclic benzimidazole derivatives useful as anti-diabetic agents
10/22/2013US8563743 Benzofuranone compound and pharmaceutical composition containing same
10/22/2013US8563742 Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
10/22/2013US8563741 CDK inhibitors containing a zinc binding moiety
10/22/2013US8563720 Method for producing imatinib base
10/22/2013US8563566 Naphthyridine derivatives as potassium channel modulators
10/22/2013US8563539 Aminopyrimidine kinase inhibitors
10/22/2013CA2619287C 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/17/2013WO2013154878A1 Heterocyclic compounds and uses thereof
10/17/2013WO2013154173A1 Amidopyridine derivative, and use thereof
10/17/2013WO2013154163A1 Novel 5-aryl-1,2-thiazinane derivative
10/17/2013WO2013154080A1 Aryloxyurea compound and pest control agent
10/17/2013WO2013152683A1 Bicycle substituted pyrazoloneazo derivatives and preparation method and use thereof
10/17/2013WO2013152392A1 Viral polymerase inhibitors
10/17/2013US20130274469 Isoxazolo-pyridine derivatives
10/17/2013US20130274468 Isoxazolo-pyridine derivatives
10/17/2013US20130274294 4-(Hetero)Aryl-Ethynyl-Octahydro-Indole-1-Esters
10/17/2013US20130274292 Ketoheteroarylpiperdine and -Piperazine Derivatives as Fungicides
10/17/2013US20130274269 Novel substituted isoquinoline derivative
10/17/2013US20130274256 Novel inhibitors of bacterial biofilms and related methods
10/17/2013US20130274254 Inhibitors of cytochrome p450 (cyp3a4)
10/17/2013US20130274242 Substituted pyrimidine compounds and their use as syk inhibitors
10/17/2013US20130274238 Combination Medicaments for Treating Bacterial Infections
10/17/2013US20130274227 3,5-diaminopyrazole kinase inhibitors
10/17/2013US20130274179 Viral polymerase inhibitors
10/17/2013US20130273569 Violet laser excitable dyes and their method of use
10/17/2013US20130273024 Methods for treating atherosclerosis
10/17/2013US20130273004 Substituted alkylamine derivatives and methods of use
10/16/2013EP2650292A1 Thiazolamine derivative and use thereof as anti-picornaviral infection medicament
10/16/2013EP2650287A1 Thiazole Derivative and use thereof as VAP-1 Inhibitor
10/16/2013EP2649065A1 Bicyclic compounds as pim inhibitors
10/16/2013EP2649064A1 Novel triazole compounds iii
10/16/2013EP2649062A1 Bicyclic compounds as inhibitors of acetyl-coa carboxylase (acc)
10/16/2013EP2649053A1 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp - pla2
10/16/2013EP2649052A1 2 -aminobenz imidazole derivatives useful in the treatment of inflammation
10/16/2013EP2649051A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
10/16/2013EP2648518A2 Pyrazole compounds for controlling invertebrate pests
10/16/2013EP2648516A1 Substituted pyridinone-pyridinyl compounds
10/16/2013CN103351360A Acylthiourea compound containing 1, 3, 4-thiadiazole group, and preparation method and application thereof
10/16/2013CN102276597B 14-membered macrolide epothilone compounds and application thereof
10/16/2013CN102126963B Spirobifluorene amido compound and preparation method thereof
10/16/2013CN102093285B Cyclic amide derivatives, and their production and use as antithrombotic agents
10/16/2013CN101784543B Indole and indazole compounds as an inhibitor of cellular necrosis
10/16/2013CN101747320B Dialdehyde-built nitrogen or oxygen-containing heterocyclic compound with insect-killing activity and preparation method
10/16/2013CN101602762B Asymmetric cyanine compound, preparation method and application thereof
10/16/2013CN101600706B Akt活性抑制剂 Akt activity inhibitor
10/16/2013CN101531657B Dimethyldiguanide of the thiazolidinedione pharmaceutical, preparation method and use thereof
10/16/2013CN101506203B 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other syndromes
10/15/2013US8557849 Fungicide hydroximoyl-tetrazole derivatives
10/15/2013US8557811 Dual-color imaging method of sodium/calcium activities using two-photon fluorescent probes and preparation method of two-photon fluorescent probes
10/15/2013US8557738 Nitrogen-containing heterocyclic derivative and fungicide for agricultural and horticultural use
10/15/2013CA2592170C Glycine derivative and use thereof
10/10/2013WO2013151923A1 Pyrimidinone carboxamides as inhibitors of endothelial lipase
10/10/2013WO2013151877A1 Pyrimidinedione carboxamide inhibitors of endothelial lipase
10/10/2013WO2013151297A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
10/10/2013WO2013149362A1 1-(dihydronaphthalenyl)pyridones as melanin-concentrating hormone receptor 1 antagonists
10/10/2013WO2013090454A3 Carboxylic acid derivatives comprising four cycles acting as glp-1 receptor modulators for therapy of diseases such as diabetes
10/10/2013WO2012030944A3 Quinoline and isoquinoline derivatives for use as jak modulators
10/10/2013US20130267713 Hepatitis C Virus Inhibitors
10/10/2013US20130267700 Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
10/10/2013US20130267569 Hydroxylated Aminotriazole Derivatives as ALX Receptor Agonists
10/10/2013US20130267538 Treatment of mitochondrial diseases
10/10/2013US20130267517 Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
10/10/2013US20130267512 Jnk inhibitors for the treatment of endometriosis
10/10/2013US20130267509 Thiazole derivatives
10/10/2013US20130267494 1,4-oxazepane derivatives
10/10/2013US20130267492 Aryl sulfonamides
10/10/2013US20130267491 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them
10/09/2013EP2646436A1 Monobactams
10/09/2013EP2646020A1 Indoles
10/09/2013CN103347880A Isoxazoline derivatives for controlling invertebrate pests
10/09/2013CN103347879A Microbiocidal pyrazole derivatives
10/09/2013CN103347872A Bicyclic compound
10/09/2013CN103347864A Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp - pla2
10/09/2013CN103342703A N-[4-(benzofuran-5-yl)thiazole-2-yl] amide as well as preparation method and application for same
10/09/2013CN103342702A D-A-A type C<^>N ligand compound as well as C<^>N ring platinum complex and application thereof
10/09/2013CN103342701A 2-Aminothiazole compound polycrystalline type as kinase inhibitors and preparation method thereof
10/09/2013CN103342696A Substituted dihydropyrazolon for treating cardiovascular and haematological diseases
10/09/2013CN102050794B Quinoxalin derivative and organic LED (Light-Emitting Diode) containing same
10/09/2013CN101821254B Adrenergic compounds
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 628